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Abstract 
Renal oncocytomas (RO) and chromophobe renal cell carcinomas (RCC) display morpho-
logical and functional alterations of the mitochondria. Previous studies showed that accu-
mulation of mitochondria in ROs is associated with somatic mutations of mitochondrial DNA 
(mtDNA) resulting in decreased activity of the respiratory chain complex I, whereas in 
chromophobe RCC only heteroplasmic mtDNA mutations were found. To identify proteins 
associated with these changes, for the first time we have compared the mitochondrial 
proteomes of mitochondria isolated from ROs and chromophobe RCCs as well as from 
normal kidney tissues by two-dimensional polyacrylamide gel electrophoresis. The proteome 
profiles were reproducible within the same group of tissues in subsequent experiments. The 
expression patterns within each group of samples were compared and 81 in-gel digested spots 
were subjected to nanoLC-MS/MS-based identification of proteins. Although the list of mi-
tochondrial proteins identified in this study is incomplete, we identified the downregulation of 
NDUFS3 from complex I of the respiratory chain and upregulation of COX5A, COX5B, and 
ATP5H from complex IV and V in ROs. In chromophobe RCCs downregulation of ATP5A1, 
the alpha subunit of complex V, has been observed, but no changes in expression of other 
complexes of the respiratory chain were detected. To confirm the role of respiratory chain 
complex alterations in the morphological and/or functional changes in chromophobe RCCs 
and ROs, further studies will be necessary.  
Key words: chromophobe renal cell carcinoma; mass spectrometry; mitochondria; renal oncocy-
toma; 2-D PAGE. 
1. Introduction 
Renal cell carcinoma (RCC) accounts for 2-3% of 
all malignant tumours. Approximately 75% of the 
renal cell tumours (RCT) are classified as conventional 
RCC, around 10% as papillary RCT, 5% each as 
chromophobe RCC and renal oncocytoma (RO) and 
the rest belongs to rare types or unclassifiable tu-
mours. Although chromophobe RCC and RO together 
account only for 10% of the RCTs, their correct diag-
nosis is important taking into account the different 
biological nature of the two tumours (1,2). Approx-
imately 90% of patients with chromophobe RCC are 
alive five years after surgery, but the rest metastasizes 
and leads to death of patients. In contrary, all ROs 
have a benign clinical course. The ages of patients Int. J. Biol. Sci. 2010, 6 
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with chromophobe RCC and RO varying considerably 
with a peak incidence in the sixth and seventh decade 
of life, respectively. Chromophobe RCC occurs 
equally in males and females, whereas RO occurs in 
males nearly twice often as in females. 
DNA studies identified complex losses of chro-
mosomes 1, 2, 6, 10, 13, 17 and 21 in 70%-97% of the 
chromophobe RCCs, whereas ROs display loss of 
chromosomes 1 and 14 and the Y chromosome or 
translocation between chromosome 11q13 and other 
chromosomes or show random genetic changes (3-9). 
The genes located at these chromosomes and involved 
in the development of chromophobe RCCs are not yet 
identified. Mutation of the p53 (at chromosome 17p) 
occurs only 25% of the cases, whereas PTEN (at 
chromosome 10q) or folliculin (at 11p13) have been 
excluded to be instrumental in the development of 
sporadic chromophobe RCCs and ROs (10-12). 
Analysis of global gene expression in distinct 
types of RCTs revealed several hundred genes, which 
are exclusively expressed in both chromophobe RCCs 
and ROs (13-17). Only few genes were assigned to be 
differentially expressed at the mRNA level and none 
of them was confirmed by protein analysis (14,16,17). 
A recent study on the expression of total cellular pro-
teins in ROs by applying the 2D-PAGE technique 
identified two proteins of the metallothionein family, 
which may be related to the abundancy of mitochon-
dria in this type of tumour (18).  
The major cytomorphological characteristic of 
chromophobe RCCs is the fine reticular cytoplasm. 
Electron microscopic studies revealed that the cha-
racteristic pale “chromophobe” staining of tumour 
cells is due to the degradation of mitochondria and 
accumulation of small intracytoplasmic vesicles. In 
contrast, cells of ROs display a strong eosinophilic 
staining due to the large number of densely packed 
mitochondria of variable size. The genetic back-
ground of these mitochondrial alterations is not yet 
cleared. Heteroplasmic mtDNA mutations found in 
chromophobe RCCs by sequencing the entire mito-
chondrial genome did not explained the number of 
mitochondria and vesicles, e.g. the staining characte-
ristics of tumour cells (19). Studies using restriction 
length polymorphism analysis have provided contra-
dictory data on mtDNA alterations in RO (20-21). 
However, recently it has been shown that somatic 
homoplasmic mtDNA mutations lead to the respira-
tory chain complex I enzyme deficiency (22). The de-
ficiency of complex I activity and protein contents has 
also been previously demonstrated (23), as well as a 
lack of its assembly (24). It is very likely that altera-
tions of mitochondrial proteins encoded in the nuclear 
DNA are responsible for the morphological abnor-
malities and hyperproliferation of mitochondria in 
cells of chromophobe RCC and RO, respectively (25).  
The intact function and morphology of mito-
chondria is relying on the coordinated expression of 
13 mitochondrial and approximately 1000 nuclear 
encoded genes (26). Global RNA or protein analysis 
results in extremely large number of candidate genes. 
The 2D-PAGE may separate around 1000 proteins and 
therefore it is an ideal technique to detect protein al-
terations in mitochondria. In this study, we used a 
proteomic approach based on two-dimensional gel 
electrophoresis and mass-spectrometry to compare 
the mitochondrial proteotypes of RO and chromo-
phobe RCC. 
2. Materials and methods  
2.1. Tumour samples  
Fresh tumour and corresponding normal pa-
renchymal tissues were obtained by nephrectomy at 
the Departments of Urology, Hannover Medical 
School and Ruprecht-Karls-University Heidelberg, 
Germany. One part of the tumour and normal kidney 
tissue was immediately snap-frozen in liquid nitrogen 
and stored at –80°C, whereas the remaining tumour 
with the nephrectomy specimen was fixed in 4 % 
buffered formalin and processed for histological ex-
amination. The histological diagnosis according to the 
Heidelberg Classification of Renal Cell Tumours was 
established by one of the authors (27). For this study 
we have selected typical cases of ROs with the cha-
racteristic morphology (Figure 1A) and electron mi-
croscopic features (Figure 1C) and also chromophobe 
RCCs showing pale “chromophobe” cytoplasmic 
staining (Figure 1B) and large number of intracytop-
lasmic microvesicles (Figure 1D). The genetic diagno-
sis of each tumour sample has been confirmed by the 
detection of specific chromosomal losses using 
high-density SNP-arrays (8). The collection and use of 
tissue samples for this study was approved by the 
Ethics Committee of the University of Heidelberg.  
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Figure 1. Characteristic cytoplasmic staining of RO (A) and chromophobe RCC (B). Hematoxilin and eosin staining, the 
same magnifications. Numerous large mitochondria of variable size are seen in the cytoplasm of cells of RO by electron 
microscopy (C). The few mitochondria in chromophobe cell are localized near to the cell membrane, whereas the cytop-
lasma is filled with small vesicles (D). The latter may be originated from the degradation of mitochondria (insert). 
 
2.2. Isolation of mitochondrial protein fractions 
All procedures were carried out at 4oC to mi-
nimize protease activity. Briefly, the cells of normal 
and tumour frozen tissues were disrupted by using 
the Dounce homogenizer (#432-1271, Wheaton, VWR 
International GmbH, Darmstadt, Germany) with 
loose and tight pestles. Up and down movements 
were carried out until getting a homogeneous 
“milk-like” suspension. The cell disruption was mo-
nitored under an inverted microscope. Homogenate 
was centrifuged at low (500 x g, Megafuge 1.0R, He-
raeus, DJB Labcare Ltd, Newport Pagnell, UK) and 
higher speed (10,000 x g, Centrifuge 5415R, Eppendorf 
Vertrieb Deutschland GmbH, Wesseling-Berzdorf, 
Germany) to sediment “nuclei, cell debris and un-
broken cells”, and to collect the crude microsomal 
fraction containing multiple kinds of microsomes 
(mitochondria, lysosome, peroxisome, Golgi complex, 
etc.). To obtain a purified fraction of mitochondria, 
sample of crude mitochondrial pellet was resus-
pended in homogenization buffer and loaded on the 
discontinuous sucrose density gradients followed by 
high-speed centrifugation (50,000 x g, Beckman Op-
tima L70K Ultracentrifuge, SW 28). Mitochondria 
were concentrated in the lowermost brown band 
(Supplementry Figure 1), carefully aspirated, washed 
and precipitated. The purified mitochondrial pellet 
was stored at –80°C until used.  
Mitochondrial integrity was tested in the iso-
lated mitochondria versus the supernatant fraction 
using anti-mitochondrial antibody (clone MTC02, 
#MS-1372-PO, Thermo scientific, Fremont, CA, USA) 
and ß-actin (#A5441, Clone AC-15, Sigma-Aldrich 
GmbH, Steinhem, Germany), respectively. For this Int. J. Biol. Sci. 2010, 6 
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purpose, mitochondrial pellet was dissolved in Lysis 
buffer (62,5 mM Tris, 2% SDS, 10% Sucrose, pH 6,8) 
containing protease inhibitors (Roche Diagnostics 
GmbH, Mannheim, Germany), and protein concen-
trations were measured by BCATM Protein Assay kit 
(# 23225, Pirce, Rockford, USA), using BSA as a stan-
dard according to the manufacturer’s instructions. 20 
µ g  o f  p r o t e i n s  w e r e  s i z e - f r a c t i o n e d  b y  1 0 %  
SDS-PAGE, transferred electrophoretically to a nitro-
cellulose membrane (Protran, Whatman GmbH, Das-
sel, Germany) and blotted with corresponding anti-
body. An enhanced chemiluminescence (Western 
LightningTM Plus-ECL, PerkinElmer LAS GmbH, 
Rodgau, Germany) system was used for the signal 
detection.  
2.3. 2-D PAGE 
The pellet of mitochondria was resuspended in 
2D Lysis buffer (7M Urea, 2M Thiourea, 4% CHAPS, 
40 mM Tris pH 7.4, 1% DTT) and total protein quan-
titation was performed using PlusOne 2-D Quant kit 
(#80-6483-56, GE Healthcare Europe GmbH, Freiburg, 
Germany) according to the manufacturer’s instruc-
tions. About 200 µg of mitochondrial proteins were 
precipitated according to the Wessel-Flügge method 
and resuspended in 200 µl of rehydration buffer (6M 
Urea, 2M Thiourea, 2% CHAPS, 0.15% DTT, 0.5% 
Ampholyte). The resuspended proteins were first se-
parated according to pI using 18 cm immobilized 
non-linear gradient strips (ImmobilineTM DryStrip, 
#17-1233-01, Amersham Biosciences Europe GmbH, 
Freiburg, Germany) covering a pH range of 3-10. The 
strips were rehydrated for 12 h and subsequently 
subjected to high voltages at 20oC for electric focusing: 
200 V for 1 h, 500 V for 1 h, 1000 V for 1 h, 8000 V 
gradient for 30 min and 8000 V for 6 h. After reduction 
for 15 min in Equilibration buffer (6M Urea, 30% 
Glycerin, 2% SDS, 50mM Tris pH 8.8, 1% DTT) and 
alkylation for an additional 15 min in the same solu-
tion containing 5% iodoacetamide, the proteins were 
separated in the second dimension in 9-16% 
SDS-PAGE gels. Spots vere visualized by staining 
wiht Coomassie brilliant blue G-250 (#161-0406, Bio-
rad Labs, Richmond, USA).  
To confirm the reproducibility and exclude ex-
perimental variations of the 2D-PAGE and also to 
detect qualitative and quantitative changes of protein 
spots the experiments we repeated by analyzing three 
ROs and three chromophobe RCCs and six normal 
samples. 
2.4. Gel analysis and protein identification 
The protein patterns in the gel were recorded in 
digitalized images using a high-resolution scanner 
(GS-710 Calibrated Imaging Densitometer, Bio-Rad, 
USA). The scanned images were analyzed using the 
Image Master 2D Platinum 6.0 software. Differentially 
expressed proteins were identified in each tumour 
sample compared to the normal kidney sample from 
six independent analyses by visual examination. 
To facilitate spot picking for protein identifica-
tion, the gels were restained with silver staining kit 
(#LC 6070, SilverQuest, Invitrogen). The excised gel 
pieces were transferred to a 96-well plate and des-
tained (28). Subsequently, the proteins were further 
reduced with DTT, alkylated with iodacedamide and 
digested with trypsin, which cleaves at the carboxylic 
side of arginine and lysine residues, using a Digest 
Pro MS liquid-handling system (Intavis AG, Cologne, 
Germany). Following digestion tryptic peptides were 
extracted from the gel pieces with 50% acetoni-
trile/0.1% TFA, concentrated nearly to dryness in a 
SpeedVac vacuum centrifuge and diluted to a total 
volume of 30 µl with 0.1% TFA. 25 µl of the sample 
was analysed by a nanoHPLC system (Eksigent, Axel 
Semrau GmbH, Sprockhövel, Germany) coupled to a 
ESI LTQ Orbitrap mass spectrometer (Thermo Fisher 
Scientific Inc., Dreiech, Germany). The sample was 
loaded on a C18 trapping column (Inertsil, LC Pack-
ings-Dionex GmbH, Idstein, Germany) with a flow 
rate of 10 µl/min 0.1% TFA. Peptides were eluted and 
separated on an analytical column (75 µm x 150 mm) 
packed with Inertsil 3 µm C18 material (LC Packings) 
with a flow rate of 200 µl/min in a gradient of buffer 
A (0.1% formic acid) and buffer B (0.1% formic acid, 
acetonitrile): 0-6 min: 3% B; 6-60 min: 3-40% B; 60-65 
m i n :  6 0 - 9 0 %  B .  T h e  c o l u m n  w a s  c o n n e c t e d  w i t h  a  
nano-ESI emitter (New Objectives Inc., Woburn, 
USA). 1300 V were applied via liquid junction. One 
survey scan (res: 30000) was followed by 3 informa-
tion dependent product ion scans in the Orbitrap (res: 
15000). 2+, 3+ and 4+ charged ions were selected for 
fragmentation.  
The uninterpreted MS/MS spectra were 
searched against the NCBInr-human database (221364 
sequences, downloaded on 29.01.2009) using the Mascot 
software (http://www.matrixscience.com). The algo-
rithm was set to use trypsin as enzyme, allowing at 
maximum for one missed cleavage site and assuming 
carbamidomethyl as a fixed modification of cysteine, 
and oxidized methionine and deamidation of aspara-
gines and glutamine as variable modifications. Mass 
tolerance was set to 4 ppm and 0.2 Da for MS and 
MS/MS, respectively. 
2.5. Gene and protein expression analysis of HSPB1 
Microarray-based gene expression study of four 
chromophobe RCCs and four ROs was carried out Int. J. Biol. Sci. 2010, 6 
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using the HG-U133 Pus2.0 GeneChip platform (Af-
fymetrix, Santa Clara, CA) as previously described 
(17). The expression data are available at the Gene 
Expression Omnibus repository 
(http://www.ncbi.nih.gov/geo) under accession 
number GSE11151.  
For validation of microarray data, real-time PCR 
analysis was applied on a panel of cDNAs obtained 
from eight chromophobe RCCs and eight ROs as well 
as from four normal kidneys as reported previously 
(17). The relative quantity was calculated by dividing 
the HSPB1 expression with the expression of ACTB. 
The following primers were used: 
5’-GCAGGACGAGCATGGCTACATCT-3’ and 
5’-GGTGACTGGGATGGTGATCTCGT-3’ for HSPB1 
and 5’-ATGGATGATGATATCGCCGCGC-3’ and 
5’-TTCTGACCCATGCCCACCATCA-3’ for ACTB. 
Western blot analysis using rabbit polyclonal 
antibody to HSPB1 (AP0274PU-S, Acris Antibodies 
GmbH, Herford, Germany) diluted 1:1000 was per-
formed on the tissue protein lysates as described 
elsewhere (17). Anti-β-actin antibody (AC-15, 
SIGMA-Aldrich GmbH, Steinhem, Germany) was 
used as a loading control. The HSPB1 antibody di-
luted 1:100 was used for immunohistochemical anal-
ysis of original paraffin blocks of fetal and adult kid-
neys, ROs and chRCCs and tissue microarrays con-
taining fetal and adult kidneys as well as of distinct 
types of kidney tumors as described previously (17). 
3. Results  
3.1. 2-D PAGE analysis of mitochondrial proteins 
The initial SDS-PAGE blotting of separated mi-
tochondria confirmed the integrity of mitochondrial 
fraction from both ROs and chromophobe RCCs 
(Supplementary Figure 1B). Individual 2D mitochon-
drial protein profiles obtained from three samples of 
RO and chromophobe RCC each, as well as from six 
normal kidneys in repeated experiments revealed a 
near-identical images within a given group (Figure 2). 
Although the contrast level of the gels of chromo-
phobe RCCs was slightly different, the majority of 
analogous protein spots showed only minimal dif-
ferences in relative location and shape. Both tumour 
types were associated with specific mitochondrial 
proteotype profile, although intensities of some of the 
spots were decreased or increased in individual tu-
mour samples as compared to those of normal kid-
neys. 
Altogether 81 spots of interest showing con-
stantly decreased or increased signal intensity in all 
three chromophobe RCCs and ROs were cut from the 
2D gel, in-gel digested with trypsin and subjected to 
nanoLC-MS/MS-based identification of proteins 
(Figure 3). The peptides were matched to all known 
human proteins in the NCBI protein database. The 
theoretical molecular weights and isoelectric points of 
the proteins, their corresponding accession numbers 
are listed in Supplementary Table 1, along with the 
protein sequence coverage in percent. Several hori-
zontal rows were seen with similar molecular size but 
slightly different isoelectric points. For example, the 
heat shock protein beta 1 was identified within five 
spots located along a line (Figure 4A, spots 63-67). 
Pertinent data of proteins showing increased or de-
creased expression in ROs and/or chromophobe 
RCCs are presented in Table 1.  
Although numerous protocols for isolation of 
mitochondria are available, we used an ultracentri-
fugation with a sucrose gradient density gradient re-
sulting in high enrichment of functional mitochondria 
compared to other methods as has been recently 
shown (29). The priority of this method is confirmed 
by the fact that the vast majority of identified proteins 
in this study are indeed annotated as mitochondrial 
proteins. Beside of the proteins with unknown func-
tion, some of identified proteins are assigned to cy-
toskeleton, which is known to be attached to the outer 
mitochondrial membrane and involved in the move-
ment of the organelle within the cell. 
3.2. Proteins differentially expressed in ROs 
We revealed the deficiency of protein 3 of com-
plex I (NDUFS3, spots 5, 6) as well as upregulation of 
two subunits of complex IV (COX5A, spots 23, 24; 
COX5B, spot 48), which are the terminal enzymes of 
the mitochondrial respiratory chain, and a subunit of 
complex V (ATP5H, spot 22), which utilizes an elec-
trochemical gradient of protons across the inner 
membrane during oxidative phosphorylation 
(OXPHOS). The proteins VDAC1 (spot 36) and 
VDAC2 (spot 30), which play a role in the control of 
cellular redox status, were up-regulated in ROs (Fig-
ure 3). The VDAC proteins can also regulate the ac-
tivity of some enzymes involved in the control of re-
dox status. For example, we found the increased level 
of superoxide dismutase (spots 38, 39) and thiore-
doxin-dependent peroxide reductase (spot 29) in RO 
as compared with normal kidney. These enzymes are 
located in the mitochondrial matrix and convert su-
peroxide radical ions produced by complex I and III of 
the electron transport chain into H2O2 which can 
subsequently be converted to water. We found an 
increased amount of a subunit of the electron transfer 
flavoprotein (spot 34) and adenylate kinase 2 (spot 
41), which is an ADP-generating enzyme localized in 
the mitochondrial intermembrane space and required Int. J. Biol. Sci. 2010, 6 
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for the maintenance of OXPHOS. These proteins 
might also be involved in the regulation of apoptosis 
by releasing from the mitochondria together with 
cytochrome c. The enoyl-CoA hydratase/isomerase 
superfamily (spots 27, 28, 31, 41) playing important 
roles in mitochondrial fatty acid β-oxidation and 
linking glycolysis and the Szent-Györgyi-Krebs cycle, 
and also a subunit of pyruvate dehydrogenase (spot 
25) were also upregulated in ROs. 
The low amount of cytochrome b5 (spot 1), a 
member of the electron transport system associated 
with the outer membrane, was easily discernable by 
visual inspection. A group of genes downregulated in 
RO includes enzymes which are involved in the 
amino acid (aminoacylase 1, spots 11, 12; lactate de-
hydrogenase B, spot 21) and lipid (apolipoprotein, 
spots 2, 3) metabolism. Apolipoprotein is a key ele-
ment of the reverse cholesterol transport pathway. 
Decreased expression of members of actin family 
(spots 18, 19) and of a protein similar to crystallin al-
pha B (spot 17), which participates in the intracellular 
architechture, was also observed in RO. These pro-
teins may be bound to the outer membrane of mito-
chondria, rather than corresponding to contaminating 
proteins within the mitochondrial fractions. 
 
 
Figure 2. Two-dimensional PAGE images of a normal kidney (A, B, C), RO (D, E, F) and chromophobe RCC (G, H, I). After 
isoelectric focusing at pH 3-10 and a 9-16% gradient SDS-PAGE gel electrophoresis independently purified samples of the 
same histological phenotype showed highly consistent protein profiles, while chromophobe RCC group has partial diversity 
(see also Supplementary Figure 1). Int. J. Biol. Sci.
Table 1. Prot
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Figure 3. Two-dimensional gel analysis of mitochondrial proteins from normal kidney tissue, RO and chromophobe RCC. 
Spots with the corresponding numbers represent differentially regulated proteins, which were subsequently identified by 
mass spectrometry. 
3.3. Differentially expressed proteins in chromophobe 
RCCs 
We observed the increased amount of superox-
ide dismutase (spot 80), which is a mitochondrial 
matrix enzyme detoxifying superoxides, and perox-
iredoxin 6 (spot 73), which is a member of antioxidant 
protein family. Two proteins involved in organelle 
trafficking, namely Ca2+-dependent adseverin (spot 
52, 53) and annexin A4 (spot 58), were also 
up-regulated in chromophobe RCCs. The degradation 
of mitochondria seen in chromophobe RCC might 
also be associated with an impaired function of the 
OXPHOS and defective mitophagy. In the present 
study, we found the over-expression of alpha subunit 
of OXPHOS complex V (ATP5A1, spot 81) and two 
subunits of the V-type proton ATPase (spots 71, 51), 
an enzyme that mediates acidification of intracellular 
organelles. The expression of prohibitin (spot 60), 
whose ring complexes in the mitochondrial inner 
membrane regulate dynamics and function of mito-
chondria by controlling cristae morphogenesis, was 
also increased in chromophobe RCC.  
A high level of isoforms of the heat shock protein 
beta-1 (HSPB1, spots 63-67), which plays a role as a 
molecular chaperon, was also observed in chromo-
phobe RCC (Figure 4A). Moreover, the increased ex-
pression of piruvate kinase isozymes M1/M2 (spot Int. J. Biol. Sci. 2010, 6 
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56) determing the glycolytic activity of cells and ca-
thepsin (spots 59, 61, 62), which is the major lysosomal 
aspartic protease, was observed in chromophobe 
RCC. Of interest, decreased expression of only three 
genes, the cytochrome b5 (spot1), pro- and apolipo-
protein (spots 2, 3) and aminoacilase (spots 11, 12) was 
seen in chromophobe RCC. 
We extended our study by analysing HSPB1 
with several approaches. Using total tissue extract, the 
HSPB1 was over-expressed in chromophobe RCCs at 
protein and RNA levels as compared with ROs (Fig-
ure 4B,C,D). Immunohistochemically, its expression 
was seen in the cytoplasm and membrane of the tu-
bular structures of the normal kidney, but not in the 
glomeruli. The cells of chromophobe RCCs showed 
strong/moderate and weak diffuse positivity, whe-
reas ROs were weakly positive or negative (not 
shown). 
 
Figure 4. The HSPB1 expression in normal kidney, RO and 
chromophobe RCC. (A) The presence of HSPB1 isoforms 
within five spots situated along a line in chromophobe RCC. 
The same zoomed areas of 2D-PAGE images shows the 
position of two spots in the dotted square. (B) Immuno-
detection of the protein with anti-HSP27 (HSPB1) antibody. 
Western blot analysis confirmed an increased expression of 
the HSPB1 protein in chromophobe RCCs in comparison 
to ROs. ACTB was used as a control. (C) A significantly 
increased mRNA level in chromophobe RCC as detected 
by microarray-based gene expression analysis (probe set 
201841_s_at). (D) Specific overexpression of the HSPB1 
gene in chromophobe RCCs in comparison to ROs has 
been confirmed by real-time PCR as well. 
4. Discussion 
The protein compositions and concentrations in 
cells and organisms are tightly regulated by a com-
plex networks. Advanced protein analysis is a prere-
quisite to explain the difference between normal and 
altered function and to differentiate between various 
stages of development of normal organs or tumours 
(30). Proteomics has been proven as efficient tools to 
analyse protein networks even in complex systems 
(31). However, the complexity of a cellular system 
often overwhelms even the best instrumentation. 
Studies on RCTs analysing whole tissue lysates by 2-D 
electrophoresis revealed a huge number of gene 
products not related to mitochondria (18). Earlier 
global RNA analyses searching for mitochondrial 
changes resulted in an extremely large number of 
candidate genes (13-17). Therefore, we reduced the 
complexity of the material by isolating subcellular 
compartments, e.g. mitochondria in the first step and 
used a proteomic approach based on 2-D gel electro-
phoresis and mass-spectrometry to compare exclu-
sively the mitochondrial proteotypes of ROs and 
chromophobe RCCs to those of normal kidneys. 
We have detected several proteins expressed 
differentially in tumour and normal kidney tissues. 
Although the list of mitochondrial proteins identified 
in this study is not complete, we have identified 
NDUFS3 from complex I of the respiratory chain as 
downregulated and COX5A, COX5B, and ATP5H 
from complex IV and V as upregulated in ROs. It is 
well known that decreased synthesis of ATP by 
OXPHOS is compensated by glycolysis, e.g. tumor 
cells shift their energy consumption from oxidative 
phosphorylation towards glucolysis, (the Warburg 
effect) (32). The growth of RO is strictly dependent on 
glucose provision and shows an increased activity of 
citrate synthase, an enzyme of the 
Szent-Györgyi-Krebs cycle (33, 22). Therefore, the 
question arises, whether the mitochondria in ROs are 
fully functional or their increased number is the result 
of an attempt to compensate their defective respira-
tory function. An increased enzymatic activity of cy-
tochrome c oxidase (complex IV) (33, 24) and high 
amount of ATPase/ATP-synthase (complex V) were 
found in ROs when compared to those of normal 
kidneys (33). In contrast, a deficiency in its activity 
and low protein amount of NADH dehydrogenase 
(complex I), which is the main gateway to the electron 
transport chain, was observed in a majority of ROs 
(23, 22, 24). Enzymatic activities of complex II and III 
were slightly increased in ROs or they were close to 
the normal level (33). The decreased activity of com-
plex I may be caused by somatic mutations of genes Int. J. Biol. Sci. 2010, 6 
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encoding this subunit rather than by regulation 
through its mRNA level or by nuclear DNA rear-
rangement (33, 22, 24). It has been hypothesized that 
increasing of free radicals or reactive oxygen species 
(ROS) production due to the high complex III activity 
could also inactivate complex I and decrease its 
amount (22). As human complex I contains at least 43 
constitutive subunits and at least three other subunits 
are involved in its assembly, mutations can not be 
excluded in any one of these subunits. 
The decreased protein content of members of 
complex I chain in RO might be compensated by the 
increased mitochondrial biogenesis or decreased mi-
tochondria specific autophagy (mitophagy), and a 
drop in any respiratory chain complex might activate 
mitochondrial proliferation (34). Indeed, complex I 
deficiency results in decreased production of ROS, 
which alter the conformation of proteins in the exter-
nal membrane of mitochondria and therefore reduce 
the mitophagy (22). It can not be excluded that low 
ROS level decreases the membrane signal for mito-
chondria elimination and programmed cell death 
(apoptosis), which may shift the balance between 
growth and apoptosis towards a slow proliferation 
tumour cells (35).  
The increased expression of pyruvate kinase 
isozymes M1/M2 may indicate an increased glyco-
lytic activity of chromophobe cells supporting the 
Warburg theory, e.g. the shift of energy consumption 
of tumour cells from OXPHOS towards glucolysis. 
The upregulation of alpha subunit of OXPHOS com-
plex V (ATP5A1) in chromophobe RCCs suggests that 
accumulation of ROS may play a role in the morpho-
logical changes of mitochondria. The over-expression 
of HSPB1 protein possibly decreases ROS generation, 
reduces cytochrome c release from the intermembrane 
space and does not allow the progression of apoptotic 
programme (36). In accordance with recently pub-
lished data (37), we found numerous isoforms of the 
HSPB1 protein due to post-translational modifications 
in chromophobe RCCs. Additionally, we showed a 
high expression of HSPB1 in chromophobe RCC both 
at the mRNA and protein level when compared with 
RO. The increased expression of cathepsin, which is 
the major lysosomal aspartic protease, was also ob-
served in chromophobe RCC. This protein is reloca-
lized to the cytoplasm in response to increased cyto-
solic levels of ROS and stimulates the translocation of 
apoptotic factor Bax onto mitochondrial membrane 
with the subsequent increasing of the mitochondrial 
VDAC, which in turn leads to the loss of membrane 
potential and release of cytochrome c involved in 
cellular apoptosis. Thus, a fine tuning between ex-
pression of these genes might be instrumental in the 
morphological changes of mitochondria in chromo-
phobe RCCs. The intensive changes of mitochondrial 
membranes and producing a high number of small 
vesicles support this hypothesis.  
Mitochondria with variable morphology un-
dergo constant migration in the cytoplasma. How the 
spatial distribution and size of mitochondria are con-
trolled in the cell is not yet cleared. It has been sug-
gested that a group of genes and cytoskeletal elements 
are engaged in the trafficking of these organelles (38). 
Recent findings indicate that superoxide radicals par-
ticipate in mitochondrial translocation, since the dis-
tribution of mitochondria may serve in compartmen-
talizing energy production and utilization (39-40). The 
translocation of mitochondria by cytoskeleton micro-
tubules from an evenly dispersed distribution to the 
submembraneous spaces resulting in perinuclear 
clearing in chromophobe cells might be triggered by 
the increased level of ROS as a protective mechanism 
to eliminate the damage effects on the nuclei.  
In summary, we found differences in the protein 
map of mitochondria isolated from ROs and chro-
mophobe RCCs that might explain the compensatory 
proliferation and membrane degradation of mito-
chondria in these tumours, respectively. The mito-
chondrial localisation and function of several gene 
products identified in this study, is not yet known. 
Disclosing the molecular mechanisms related to the 
morphological and functional changes of mitochon-
dria in chromophobe RCCs and ROs is important to 
understand the development of these two unique 
types of tumours. Therefore, these proteins should 
further be characterized and assigned to the mito-
chondrial, nuclear and cytosolic compartments of 
normal kidney cells by Western blotting. Subse-
quently, proteins ordered to the mitochondria should 
be localized by immunoelectron microscopic studies 
of normal and tumour cells to the specific structures 
of normal and altered mitochondria, especially to mi-
crovesicles in tumour cells. 
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